Home / Drug shortages / Etomidate Injection

Etomidate Injection — FDA Drug Shortage

Current — Hikma Pharmaceuticals USA, Inc.

The FDA lists a drug shortage record for Etomidate Injection (injection) from Hikma Pharmaceuticals USA, Inc. with status Current. The shortage was first posted on 10/05/2022.

Shortage Details

Status
Current
Company
Hikma Pharmaceuticals USA, Inc.
Package NDC
0143-9506-10
Dosage Form
Injection
Presentation
Etomidate, Injection, 2 mg/1 mL (NDC 0143-9506-10)
Initial Posting
10/05/2022
Revised Date

FDA data resources